You have 9 free searches left this month | to do more
Showing 1 - 25 of
611 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
J
Active, not recruiting
  • Multiple Myeloma
  • Daratumumab Subcutaneous (SC) Administration
  • Recombinant Human Hyaluronidase [rHuPH20]) SC Administration
  • Atlanta, Georgia
  • +11 more
2021-12-02
Dec 2, 2021
J
Active, not recruiting
  • Multiple Myeloma
  • Beijing, China
  • +4 more
2021-12-02
Dec 2, 2021
J
M
Active, not recruiting
  • Prostate Adenocarcinoma
  • +5 more
  • Daratumumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2020-03-19
Mar 19, 2020
V
Active, not recruiting
  • Multiple Myeloma
  • all-trans retinoic acid (ATRA)
  • Amsterdam, NH, Netherlands
    VU University Medical Center
2021-10-05
Oct 5, 2021
J
Active, not recruiting
  • Hepatitis B, Chronic
  • Bakersfield, California
  • +107 more
2021-11-23
Nov 23, 2021
M
Active, not recruiting
  • Bladder Urothelial Carcinoma
  • +4 more
  • Biopsy
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-05-11
May 11, 2021
M
Recruiting
  • Multiple Myeloma
  • Basking Ridge, New Jersey
  • +6 more
2021-12-02
Dec 2, 2021
H
Recruiting
  • Multiple Myeloma
  • 89Zr-daratumumab PET/CT
  • Irvine, California
    Hoag Memorial Hospital Presbyterian
2021-03-23
Mar 23, 2021
J
Completed
  • Healthy
  • Beijing, China
    Peking University Third Hospital
2021-03-04
Mar 4, 2021
J
Recruiting
  • Multiple Myeloma
  • Carfilzomib 20 mg/m^2
  • +4 more
  • Gilbert, Arizona
  • +113 more
2021-12-02
Dec 2, 2021